These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6341265)

  • 21. The mechanisms of immune suppression by high-pressure stress in mice.
    Fujiwara R; Shibata H; Komori T; Yokoyama MM; Okazaki Y; Ohmori M
    J Pharm Pharmacol; 1999 Dec; 51(12):1397-404. PubMed ID: 10678494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible role of PMN in a casein-induced enhancement of PFC response to sheep erythrocytes in mice.
    Nakayama S; Rodriguez-Pinzon J; Nakamura S; Yoshinaga M
    Immunology; 1982 Apr; 45(4):669-77. PubMed ID: 7040213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avidities of hapten-specific antibodies when the responses are modulated by anti-carrier antibodies.
    Whited Collisson E; Andersson B; Lamon EW
    Immunology; 1984 Nov; 53(3):443-9. PubMed ID: 6386675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism.
    Maestroni GJ; Conti A; Pierpaoli W
    Clin Exp Immunol; 1987 May; 68(2):384-91. PubMed ID: 3308215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
    Reinertsen JL; Steinberg AD
    J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific unresponsiveness to sheep red blood cells visualized by levamisole in athymic nude mice.
    Holub M; Hraba T; Madar J
    Immunopharmacology; 1982 Dec; 5(2):129-34. PubMed ID: 6761306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immune response of CBA/N mice and their F1 hybrids to 2,4,6-trinitrophenylated antigens. II. Avidity profiles of secondary IgM and IgG responses to TNP-KLH.
    Quan ZS; Satin AJ; Quintáns J
    Cell Immunol; 1981 Jul; 61(2):448-52. PubMed ID: 7018702
    [No Abstract]   [Full Text] [Related]  

  • 28. The potentiality of antibody-producing cells. II. Evidence for two antibody molecules of different specificities secreted by micromanipulated bispecific mouse spleen cells.
    Couderg J; Bleux C; Liacopoulos P
    Immunology; 1975 Oct; 29(4):665-74. PubMed ID: 52617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells.
    Schrater AF; Goidl EA; Thorbecke GJ; Siskind GW
    J Exp Med; 1979 Jul; 150(1):138-53. PubMed ID: 312903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human lymphocytes can generate thymus-independent as well as thymus-dependent anti-hapten plaque-forming cell responses in vitro.
    Golding B; Chang SP; Golding H; Jones RE; Pratt KL; Burger DR; Rittenberg MB
    J Immunol; 1981 Jul; 127(1):220-4. PubMed ID: 6165766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment.
    Cross RJ; Jackson JC; Brooks WH; Sparks DL; Markesbery WR; Roszman TL
    Immunology; 1986 Jan; 57(1):145-52. PubMed ID: 3080368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of arecoline on immune system: III. Suppression of B cell-mediated immune response in mice after short-term exposure.
    Selvan RS; Rao AR
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):291-305. PubMed ID: 8349954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between immunization and circulating antigen-specific plaque-forming cells.
    Falkoff RJ; Zhu LP; Fauci AS
    Cell Immunol; 1983 Jun; 78(2):392-9. PubMed ID: 6190578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of in vivo antibody responses by cholera toxin.
    Kateley JR; Kasarov L; Friedman H
    J Immunol; 1975 Jan; 114(1 Pt 1):81-4. PubMed ID: 163279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of plaque-forming cells with anti-idiotope or hapten: variation due to hapten density on indicator red cells.
    Cronkhite R; Cerny J; DeLisi C
    J Immunol Methods; 1984 Mar; 68(1-2):109-18. PubMed ID: 6200538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proliferative activity of antibody forming cells in the mouse bone marrow.
    Koch G; Lok BD; Benner R
    Adv Exp Med Biol; 1982; 149():75-81. PubMed ID: 6756081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular requirements for thyrotropin enhancement of in vitro antibody production.
    Kruger TE; Blalock JE
    J Immunol; 1986 Jul; 137(1):197-200. PubMed ID: 3086448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas.
    Xue B; Coico R; Wallace D; Siskind GW; Pernis B; Thorbecke GJ
    J Exp Med; 1984 Jan; 159(1):103-13. PubMed ID: 6363593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the immune response. I. Differential effect of passively administered antibody on the thymus-derived and bone marrow-derived lymphocytes.
    Kappler JW; Hoffmann M; Dutton RW
    J Exp Med; 1971 Sep; 134(3 Pt 1):577-87. PubMed ID: 15776562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of glucocorticoids and heparin on the humoral immune response of mice.
    Jókay I; Kelemenics K; Karczag E; Földes I
    Immunobiology; 1980 Dec; 157(4-5):390-400. PubMed ID: 7005084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.